← Leaderboards
Rajeev Malhotra
Massachusetts General Hospital
$7,038,841
Attributed
$9,278,302
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,278,302 · 4
By mechanism
R01$8,482,342 · 3
K08$795,960 · 1
Top collaborators
- Gregory Dyer Lewis4 shared
- Paul Stefan De Vries3 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Paul B Yu$13,557,400
- Herbert Y Lin$7,187,681
- Jodie L Babitt$8,318,929
- Kenneth D Bloch$14,282,889
- Gregory Dyer Lewis$6,901,253
Others in their field
Top investigators on “Signal Pathway”
- David Heimbrook · Leidos Biomedical Research, Inc.$191,912,844
- Asrar B. Malik · University Of Illinois At Chicago$75,811,832
- Robert H Tukey · University Of California San Diego$50,504,865
- Meenhard Herlyn · University Of Pennsylvania$50,308,097
- Ian A Wilson · Scripps Research Institute, The$50,300,809
- Richard D Smith · Battelle Pacific Northwest Laboratories$46,192,560
Research focus
Signal PathwayPlayInsightPhenotypeBlood VesselsCardiovascular DiseasesMorbidity - Disease RateMortalityPeripheral Arterial DiseaseMyocardial InfarctionMediatingCellsMemberMolecularIn VivoOsteogenicArteriesGenetic DeterminismCalcificationIn VitroBone Morphogenetic ProteinsCardiovascular Risk FactorEventPathway Interactions
Grant awards (18)
The Role of Arylsulfatase in Vascular Calcification$628,601
R01 · FY2025 · HL · contact PI
The Role of Arylsulfatase in Vascular Calcification$657,994
R01 · FY2024 · HL · contact PI
Characterization of Functional Iron Deficiency and Repletion in Heart Failure with Preserved Ejection Fraction$601,100
R01 · FY2024 · HL
The Role of Arylsulfatase in Vascular Calcification$709,203
R01 · FY2023 · HL · contact PI
Characterization of Functional Iron Deficiency and Repletion in Heart Failure with Preserved Ejection Fraction$614,281
R01 · FY2023 · HL
The Role of Histone Deacetylase 9 in Vascular Calcification$637,501
R01 · FY2022 · HL · contact PI
Characterization of Functional Iron Deficiency and Repletion in Heart Failure with Preserved Ejection Fraction$624,106
R01 · FY2022 · HL
Characterization of Functional Iron Deficiency and Repletion in Heart Failure with Preserved Ejection Fraction$643,638
R01 · FY2021 · HL
The Role of Histone Deacetylase 9 in Vascular Calcification$637,501
R01 · FY2021 · HL · contact PI
The Role of Histone Deacetylase 9 in Vascular Calcification$743,609
R01 · FY2020 · HL · contact PI
The Role of Histone Deacetylase 9 in Vascular Calcification$637,501
R01 · FY2020 · HL · contact PI
The Role of Histone Deacetylase 9 in Vascular Calcification$637,501
R01 · FY2019 · HL · contact PI
The Role of Histone Deacetylase 9 in Vascular Calcification$709,806
R01 · FY2018 · HL · contact PI
The Role of Bone Morphogenetic Proteins in Vascular Calcification$173,880
K08 · FY2018 · HL · contact PI
The Role of Bone Morphogenetic Proteins in Vascular Calcification$173,880
K08 · FY2017 · HL · contact PI
The Role of Bone Morphogenetic Proteins in Vascular Calcification$173,880
K08 · FY2016 · HL · contact PI
The Role of Bone Morphogenetic Proteins in Vascular Calcification$137,160
K08 · FY2015 · HL · contact PI
The Role of Bone Morphogenetic Proteins in Vascular Calcification$137,160
K08 · FY2014 · HL · contact PI